These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 24074710

  • 1. [Supplemental Fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis B following unsatisfactory outcome of nucleos(t)ide analogue monotherapy].
    Tian YL, Zhu XY, Yin WW, Zang ZD, Wang L, Fu XL.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):514-8. PubMed ID: 24074710
    [Abstract] [Full Text] [Related]

  • 2. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [Abstract] [Full Text] [Related]

  • 3. [The value of serum markers in evaluating liver fibrotic changes].
    Hu YY, Liu P, Liu C, Liu CH, Xu LM.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):174-7. PubMed ID: 16556409
    [Abstract] [Full Text] [Related]

  • 4. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B.
    Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Zhou RX, He J, Tang BZ.
    World J Gastroenterol; 2005 May 21; 11(19):2892-9. PubMed ID: 15902724
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic efficacy and quality of life investigation of traditional Chinese medicine-based therapy of chronic hepatitis B-related liver fibrosis].
    An J, Ni W, Qiao J.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan 21; 22(1):30-2. PubMed ID: 24721240
    [Abstract] [Full Text] [Related]

  • 6. [The therapeutic effect of Anluohuaxian capsule combined with adefovir dipivoxil on patients with chronic hepatitis B and influence on hepatic histology].
    Jiang YF, Ma J, He B, Li NP, Tang W, Gong GZ.
    Zhonghua Gan Zang Bing Za Zhi; 2012 May 21; 20(5):344-7. PubMed ID: 22971278
    [Abstract] [Full Text] [Related]

  • 7. Histological response to combination therapy with nucleos(t)ide analogs and peginterferon alpha in treatment-naïve chronic hepatitis B patients.
    Zhang Q, Li G, Yu Y, Qiu C, Zheng J, Zhang H, Zhang M, Song Z, Yang Y, Du X, Hong J, Lu J, Li N, Tang Q, Xu L, Wang X, Huang Y, Zhang J, Chen Z, Zhang W.
    J Viral Hepat; 2019 Jul 21; 26 Suppl 1():59-68. PubMed ID: 31380588
    [Abstract] [Full Text] [Related]

  • 8. [Clinical effect of combination therapy with Fufang Biejia Ruangan tablet and entecavir in patients with hepatitis B virus-related cirrhosis].
    Wu G, He H, Li H, Chen W.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug 21; 22(8):604-8. PubMed ID: 25243962
    [Abstract] [Full Text] [Related]

  • 9. [Intervention of chronic hepatitis B liver fibrosis patients in different stages by syndrome typing and different activating blood removing stasis methods: a clinical study].
    Liu SY, Zhang YQ, Liu YL, Guo P, Zhou CM.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov 21; 33(11):1457-61. PubMed ID: 24483103
    [Abstract] [Full Text] [Related]

  • 10. [Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment].
    Hu YY, Liu P, Liu C.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan 21; 26(1):18-22. PubMed ID: 16466166
    [Abstract] [Full Text] [Related]

  • 11. [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].
    Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Tang BZ, He J.
    Zhong Xi Yi Jie He Xue Bao; 2003 Jul 21; 1(2):89-98, 102. PubMed ID: 15339577
    [Abstract] [Full Text] [Related]

  • 12. [Clinical research of xinganbao capsule on the treatment of chronic hepatitis B liver fibrosis].
    Wang XB, Jiang YY, Zhao CY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Mar 21; 32(3):325-8. PubMed ID: 22686076
    [Abstract] [Full Text] [Related]

  • 13. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D, Fard MK, Agcheli K.
    J Gastrointestin Liver Dis; 2010 Jun 21; 19(2):169-74. PubMed ID: 20593050
    [Abstract] [Full Text] [Related]

  • 14. [Serum fibrosis markers in diagnosing liver fibrosis].
    Liu J, Wang JY, Lu Y.
    Zhonghua Nei Ke Za Zhi; 2006 Jun 21; 45(6):475-7. PubMed ID: 16831325
    [Abstract] [Full Text] [Related]

  • 15. [Clinical study on treatment of liver fibrosis in patients of hepatitis B by kangxian baogan decoction].
    Liang TJ, Zhang W, Zhang CQ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May 21; 22(5):332-4. PubMed ID: 12584827
    [Abstract] [Full Text] [Related]

  • 16. Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents.
    Kim CH, Um SH, Seo YS, Jung JY, Kim JD, Yim HJ, Keum B, Kim YS, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS.
    J Gastroenterol Hepatol; 2012 Oct 21; 27(10):1589-95. PubMed ID: 22554121
    [Abstract] [Full Text] [Related]

  • 17. Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?
    Papatheodoridis GV.
    Liver Int; 2013 Feb 21; 33 Suppl 1():151-6. PubMed ID: 23286859
    [Abstract] [Full Text] [Related]

  • 18. Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial.
    Qu J, Yu Z, Li Q, Chen Y, Xiang D, Tan L, Lei C, Bai W, Li H, Shang Q, Chen L, Hu X, Lu W, Li Z, Chen D, Wang X, Zhang C, Xiao G, Qi X, Chen J, Zhou L, Chen G, Li Y, Zeng Z, Rong G, Dong Z, Chen Y, Lou M, Wang C, Lu Y, Zhang C, Yang Y.
    Trials; 2014 Nov 10; 15():438. PubMed ID: 25381721
    [Abstract] [Full Text] [Related]

  • 19. [Comparison on efficacy in treating liver fibrosis of chronic hepatitis B between Astragalus Polygonum anti-fibrosis decoction and jinshuibao capsule].
    Chen H, Weng L.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Apr 10; 20(4):255-7. PubMed ID: 11789260
    [Abstract] [Full Text] [Related]

  • 20. [The clinical study on chronic hepatitis B treated by the four-step therapeutics of Traditional Chinese Medicine].
    Yang HZ, Wang FL, Wang YZ, Shen WS, Xu GL, Yang YW, Huang XL.
    Zhong Yao Cai; 2006 Jul 10; 29(7):748-52. PubMed ID: 17059015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.